SANTAMARIA, FIORENZA
 Distribuzione geografica
Continente #
EU - Europa 94
AS - Asia 39
NA - Nord America 24
OC - Oceania 1
Totale 158
Nazione #
IT - Italia 70
US - Stati Uniti d'America 24
IN - India 14
SG - Singapore 14
IR - Iran 8
FI - Finlandia 6
FR - Francia 6
BE - Belgio 3
BG - Bulgaria 3
CH - Svizzera 2
GB - Regno Unito 2
TW - Taiwan 2
DE - Germania 1
KG - Kirghizistan 1
NZ - Nuova Zelanda 1
SE - Svezia 1
Totale 158
Città #
Rome 23
Milan 15
Helsinki 6
Singapore 6
West Jordan 6
Ashburn 5
Fonte Nuova 4
Gurugram 4
Paris 4
Rotondi 4
Bengaluru 3
Boardman 3
Brussels 3
Pescara 3
Sofia 3
Castano Primo 2
Isfahan 2
Kottayam 2
Naples 2
Palermo 2
Paola 2
Romainville 2
Taipei 2
Zurich 2
Bishkek 1
Bonndorf 1
Cuttack 1
Kilburn 1
Leigh-on-Sea 1
Lower Hutt 1
Perugia 1
Prato 1
Pune 1
Tehran 1
Totale 120
Nome #
Comparative Analysis of Regorafenib and Trifluridine/Tipiracil in Later-Line Refractory Metastatic Colorectal Cancer: A Real-Life Multicenter Retrospective Study 60
Sequential treatment with regorafenib and trifluridine/tipiracil in later-line refractory metastatic colorectal cancer: A real-world multicenter retrospective study 49
398P Effectiveness and safety of regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A real-world multicenter retrospective study with focus on sequential treatment 23
Treatment settings and outcomes with Regorafenib and Trifluridine/Tipiracil at third-line treatment and beyond in metastatic colorectal cancer: a real-world multicenter retrospective study 16
Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments 7
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis 5
P-368 Efficacacy of trifluridine/tipiracil according to extended RAS evaluation: A multicenter retrospective analysis 4
P-360 Efficacy of regorafenib according to extended RAS evaluation: A multicenter retrospective analysis 4
P-195 Influence of age on disease control rate of patients treated with regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A multicenter retrospective real-world study 4
Treatment of patients with BRAF-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset 4
Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis 2
Totale 178
Categoria #
all - tutte 750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202359 0 0 0 0 0 0 0 19 25 3 6 6
2023/2024113 5 9 16 14 12 4 4 11 4 20 0 14
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 178